Life Sciences Startups Slimming Space Needs During Downturn Hit by an economic slowdown and a more cautious approach from biotech VCs, life sciences startups have adjusted their playbooks and pulled back from an era of larger leases and rapid expansion, instead shrinking leases, splitting workspace between incubators and leaning on remote staff and contract research. But despite this shift, landlords have yet to feel the pain from a more fiscally conservative pivot by startups, according to analysts. The context of the moment is important, they say, because companies are still doing business, they’re just being more cautious. “New firms aren’t being brazen,” Cushman & Wakefield Senior Managing Director of Project & Development Services Jason D'Orlando said. “They’re leaning towards more condensed areas, or partnering with other firms, or working more with contract research or manufacturing firms.” 
The slowdown in funding over the second half of the year has been pronounced. Carta, a firm that tracks startup investment via its own proprietary fundraising data set, found that early stage biotech funding has taken a dive since hitting a peak last fall. Seed funding in this sector, which…  Read the full story here. | 
